Literature DB >> 1601535

Presentation of results from bioequivalence studies.

R Sauter1, V W Steinijans, E Diletti, A Böhm, H U Schulz.   

Abstract

Based on general guidelines and requirements for the design and analysis of bioequivalence studies, specific recommendations are made for the presentation of results, both in tabular and graphical form. This is done by means of two examples, one of a single-dose study and one of a multiple-dose study. The recommendations in this paper are twofold. Firstly, a complete and rather detailed presentation of results is given, which practically corresponds to the standard of research reports. Secondly, a subset of this is suggested for publication. It gives the essential results for bioequivalence assessment in a standardized form. From an editorial point of view, it would be highly appreciated if the papers submitted for publication were always accompanied by a complete presentation including the individual concentration/time data and the various steps of calculation. This would speed up peer review and ultimately improve and harmonize the standard of bioequivalence publications.

Mesh:

Substances:

Year:  1992        PMID: 1601535

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  5 in total

Review 1.  Bioequivalence of controlled-release calcium antagonists.

Authors:  R Schall; F R Müller; F O Müller; H G Luus
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

2.  Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studies.

Authors:  Helmut Schütz; Detlew Labes; Anders Fuglsang
Journal:  AAPS J       Date:  2014-09-12       Impact factor: 4.009

3.  Transdermal absorption of ethanol- and 1-propanol-containing hand disinfectants.

Authors:  Reinhold Andreas Lang; Dianne Egli-Gany; Florian Holger Hubert Brill; Johannes Georg Böttrich; Marion Breuer; Burkhard Breuer; Martin Hartwig Kirschner
Journal:  Langenbecks Arch Surg       Date:  2010-12-01       Impact factor: 3.445

4.  Ambroxol lozenge bioavailability : an open-label, two-way crossover study of the comparative bioavailability of ambroxol lozenges and commercial tablets in healthy thai volunteers.

Authors:  Malee Rojpibulstit; Srirat Kasiwong; Siwasak Juthong; Narubodee Phadoongsombat; Damrongsak Faroongsarng
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

5.  Pharmacokinetics and comparative bioavailability of two metformin formulations after single-dose administration in healthy subjects.

Authors:  Ivanka Atanasova; Kristina Bozhinova; Denitza Todorova; Dimiter Terziivanov
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.